Vimarsana
Biggest News Aggregation in the World

Page 2 - Proprietary Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Proprietary Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Proprietary Technology Today - Breaking & Trending Today

Decoding Interactive Brokers Group Inc (IBKR): A Strategic SWOT Insight - Vimarsana News

Decoding Interactive Brokers Group Inc (IBKR): A Strategic SWOT Insight

Unveiling the Strengths and Challenges: A Deep Dive into Interactive Brokers Group Inc (IBKR) SWOT Analysis

Source: yahoo.com
WPP plc (NYSE:WPP) Q4 2023 Earnings Call Transcript - Vimarsana News

WPP plc (NYSE:WPP) Q4 2023 Earnings Call Transcript

WPP plc (NYSE:WPP) Q4 2023 Earnings Call Transcript February 22, 2024 WPP plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Mark Read: Thank you very much and welcome everybody to WPP’s Preliminary Results for 2023. I’m Mark Read. I’m joined […]

Source: yahoo.com
Motive countersues fleet tech rival Samsara over patent infringement - Vimarsana News

Motive countersues fleet tech rival Samsara over patent infringement

Fleet telematics provider Motive Technologies filed a lawsuit Thursday alleging Samsara Inc. copied and used its proprietary technology and patents. The post Motive countersues fleet tech rival Samsara over patent infringement appeared first on FreightWaves.

Source: yahoo.com
iNtRON, Development of PHAGERIA® Anti-Cancer Candidate with Enhanced Antimicrobial Activity by Robot Bacteriophage platform technology - Vimarsana News

iNtRON, Development of PHAGERIA® Anti-Cancer Candidate with Enhanced Antimicrobial Activity by Robot Bacteriophage platform technology

▶ Robot Bacteriophage against microbiome associated with colorectal cancer ▶ Bacteriophage Improvement Platform technology with a broad antimicrobial activity ▶ Proprietary Technology incorporating CRISPR/Cas Technology BOSTON, Feb. 15, 2024 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that New Drug Part has secured a potent anti-cancer candidate, PHAGERIA®, with broad antimicrobial activity against ETBF (Enterotoxigenic B. fragilis), a...

Enova International Inc CFO Steven Cunningham Sells 17,548 Shares - Vimarsana News

Enova International Inc CFO Steven Cunningham Sells 17,548 Shares

Steven Cunningham, the Chief Financial Officer of Enova International Inc, executed a sale of 17,548 shares of the company on February 9, 2024, according to a recent SEC Filing.

Source: yahoo.com